Global Sexually Transmitted Infections Programme
The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of sexually transmitted infections as a public health threats.

Key data on STIs

All →
Incident cases of 4 curable STIs, 2020
WHO
© Credits

Publications

All →
The adolescent health indicators recommended by the Global Action for Measurement of Adolescent health

About 1.3 billion of the world’s population are adolescents, defined as those aged 10-19 years. Adolescents bear long periods of exposure to, and...

Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for men who have sex with men

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These...

Recommended package of 
interventions for HIV, viral hepatitis 
and STI prevention, diagnosis, 
treatment and care for sex workers

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations....

Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 
2022–2030: report on progress and gaps 2024

This report is the first of a series of biennial progress reports on the implementation of the Global health sector strategies on HIV, viral hepatitis...

Medicines for HIV, viral hepatitis, and sexually transmitted infections in low- and middle-income countries:
forecasts of global demand for 2022 – 2026

For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted...

Introducing a framework for implementing triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus: policy brief

Triple elimination of mother-to-child transmission (MTCT) of HIV, syphilis and hepatitis B virus (HBV) requires a person- centred service delivery approach...

Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): surveillance report 2022

The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) was developed to address many of GASP’s limitations and strengthen sentinel...

Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): supplementary protocols

Widespread antimicrobial resistance (AMR) in highly variable strains of Neisseria gonorrhoeae continues to cause significant public health concerns and...